Goodwin advised AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) in the completion of its $300 million aggregate principal amount of 3.25% convertible senior notes due 2022 in an…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now